Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Initially developed as an anti-obesity agent, AOD 9604 is designed to promote fat metabolism without influencing blood glucose levels, IGF-1 production, or lean muscle growthoffering the lipolytic benefits of hGH with significantly reduced risk of hormonal side effects
News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004
Individual animal dosing is far more reliable than trough or pasture treatment
This comprehensive guide examines the AOD-9604 appetite-neutral fat loss process, covering its unique mechanism of action, the scientific research demonstrating its metabolic specificity, practical dosing protocols, safety profile, and what makes this peptide fundamentally different from both appetite suppressants and compounds that stimulate hunger
Any side effects or unusual symptoms should be documented
International Journal of Molecular Sciences (2018) 10
US$ 23.53
US$ 27.93
US$ 21.34
US$ 23.85
US$ 25.23
